Mylan Asks High Court If ANDA Subjects Filers To Specific Personal Jurisdiction

(September 30, 2016, 9:24 AM EDT) -- WASHINGTON, D.C. — Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, Mylan) ask the U.S. Supreme Court in a Sept. 19 petition whether the filing of an abbreviated new drug application (ANDA)...

To view the full article, register now.